Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?
Della Rossa
A
A
Tavoni
A
A
Merlini
G
G
Baldini
C
C
Sebastiani
M
M
Lombardi
M
M
Neglia
D
D
Bombardieri
S
S
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D013625:Takayasu Arteritis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab